Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Feb;19(1):17-23.
doi: 10.1016/j.drugpo.2007.11.019. Epub 2008 Jan 15.

Ethical and human rights imperatives to ensure medication-assisted treatment for opioid dependence in prisons and pre-trial detention

Affiliations

Ethical and human rights imperatives to ensure medication-assisted treatment for opioid dependence in prisons and pre-trial detention

R Douglas Bruce et al. Int J Drug Policy. 2008 Feb.

Abstract

Opioid dependence is a complex medical condition affecting neurocognitive and physical functioning. Forced or abrupt opioid withdrawal may cause profound physical and psychological suffering, including nausea, vomiting, diarrhoea, extreme agitation and/or anxiety. Opioid-dependent individuals are especially vulnerable at the time of arrest or initial detention, when they may, as a result of their chemical dependency, be coerced into providing incriminating testimony, or be driven to engage in risky behaviour (such as sharing needles in detention) in order to avoid painful withdrawal symptoms. Upon incarceration, many opioid-dependent prisoners are forced to undergo abrupt opioid withdrawal (both from legally prescribed agonist therapy such as methadone as well as illicit opioids). Physical and psychological symptoms attendant to withdrawal may impair capacity to make informed legal decisions, and cause prisoners to risk HIV and other blood-borne diseases by sharing injection equipment. Although prisons must provide at least the standard of care to prisoners that is available in the general population, medication-assisted treatment, endorsed by international health and drug agencies as an integral part of HIV prevention and care strategies for opioid-dependent drug users, is unavailable to most prisoners. Medication-assisted treatment is a well-studied and validated pharmacological therapy for the medical condition known as opioid dependence. The failure to ensure prisoner access to this medical therapy threatens fundamental human rights protections against cruel, inhuman or degrading treatment and rights to health and to life. It also poses serious ethical problems for health care providers, violating basic principles of beneficence and non-maleficence (i.e., do good/do no harm). Governments must take immediate action to ensure access to opioid substitution to prisoners to ensure fulfilment of ethical and human rights obligations.

PubMed Disclaimer

References

    1. Beck A, Gillard D, Greenfeld L, Harlow C, Hester T, Jankowski L, Snell T, Stephan J, Morton D. Survey of State Prison Inmates. US Department of Justice, Bureau of Justice Statistics; Washington, DC: 1993. 1991.
    1. Belenko S, Peugh J, Usdansky M, Kurzweil B, Liu H, Foster S. Behind Bars: Substance Abuse and America's Prison Population. National Center on Addiction and Substance Abuse; New York: 1998.
    1. Beyrer C, et al. Drug Use, Increasing Incarceration Rates, and Prison-Associated HIV Risks in Thailand. AIDS and Behavior. 2003;7(2):153–64. - PubMed
    1. Boys A, et al. Drug use and initiation in prison: results from a national prison survey in England in Wales. Addiction. 2002;97(2002):1551–60. - PubMed
    1. Calzavara LM, Burchell AN, Schlossberg J, et al. Prior opiate injection and incarceration history predict injection drug use among inmates. Addiction. 2003;98(9):1257–1265. - PubMed

Publication types

MeSH terms